TBX1 and neoplasm: CAFs contribute significantly to remodeling the ECM by increasing the deposition of matrix components, which triggers the fibrosis of intratumoral vessels and thus obstructs the infiltration of immune effector cells and the delivery of therapy to the tumor site.